MXPA97001795A - Coloring copuard for anali spectrophotometric determination - Google Patents
Coloring copuard for anali spectrophotometric determinationInfo
- Publication number
- MXPA97001795A MXPA97001795A MXPA/A/1997/001795A MX9701795A MXPA97001795A MX PA97001795 A MXPA97001795 A MX PA97001795A MX 9701795 A MX9701795 A MX 9701795A MX PA97001795 A MXPA97001795 A MX PA97001795A
- Authority
- MX
- Mexico
- Prior art keywords
- test device
- further characterized
- enzymes
- alkyl
- oxidase
- Prior art date
Links
- 238000004040 coloring Methods 0.000 title description 4
- 238000002798 spectrophotometry method Methods 0.000 title 1
- 238000012360 testing method Methods 0.000 claims abstract description 33
- 102000004190 Enzymes Human genes 0.000 claims abstract description 24
- 108090000790 Enzymes Proteins 0.000 claims abstract description 24
- 239000012491 analyte Substances 0.000 claims abstract description 23
- 150000001875 compounds Chemical class 0.000 claims abstract description 13
- 239000007800 oxidant agent Substances 0.000 claims abstract description 12
- 229940088598 enzyme Drugs 0.000 claims description 23
- 125000000217 alkyl group Chemical group 0.000 claims description 12
- -1 thioalkoxide Chemical class 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 11
- 150000001412 amines Chemical group 0.000 claims description 10
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 9
- 108010015776 Glucose oxidase Proteins 0.000 claims description 6
- 150000007942 carboxylates Chemical class 0.000 claims description 6
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims description 6
- 239000004366 Glucose oxidase Substances 0.000 claims description 5
- 125000003118 aryl group Chemical group 0.000 claims description 5
- 229940116332 glucose oxidase Drugs 0.000 claims description 5
- 235000019420 glucose oxidase Nutrition 0.000 claims description 5
- 150000004820 halides Chemical class 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims description 5
- 102000003992 Peroxidases Human genes 0.000 claims description 4
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 4
- 108010025188 Alcohol oxidase Proteins 0.000 claims description 3
- 108010089254 Cholesterol oxidase Proteins 0.000 claims description 3
- 108010041921 Glycerolphosphate Dehydrogenase Proteins 0.000 claims description 3
- 102000000587 Glycerolphosphate Dehydrogenase Human genes 0.000 claims description 3
- 150000004703 alkoxides Chemical class 0.000 claims description 3
- 125000000623 heterocyclic group Chemical group 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 150000007524 organic acids Chemical group 0.000 claims description 3
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 claims description 3
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 3
- 125000003107 substituted aryl group Chemical group 0.000 claims description 3
- LJCNDNBULVLKSG-UHFFFAOYSA-N 2-aminoacetic acid;butane Chemical compound CCCC.CCCC.NCC(O)=O LJCNDNBULVLKSG-UHFFFAOYSA-N 0.000 claims description 2
- 108091023020 Aldehyde Oxidase Proteins 0.000 claims description 2
- 102000048262 Aldehyde oxidases Human genes 0.000 claims description 2
- 230000006872 improvement Effects 0.000 claims description 2
- 229910021432 inorganic complex Inorganic materials 0.000 claims description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims 1
- 108010092464 Urate Oxidase Proteins 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 14
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 16
- PHOLIFLKGONSGY-CSKARUKUSA-N (e)-(3-methyl-1,3-benzothiazol-2-ylidene)hydrazine Chemical compound C1=CC=C2S\C(=N\N)N(C)C2=C1 PHOLIFLKGONSGY-CSKARUKUSA-N 0.000 description 14
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 13
- 239000008103 glucose Substances 0.000 description 13
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 12
- 239000011159 matrix material Substances 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- 239000000203 mixture Substances 0.000 description 8
- 238000007254 oxidation reaction Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 239000007788 liquid Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 239000003086 colorant Substances 0.000 description 5
- 238000007654 immersion Methods 0.000 description 5
- 230000003647 oxidation Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Substances C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 150000007857 hydrazones Chemical class 0.000 description 3
- 230000001590 oxidative effect Effects 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 150000004982 aromatic amines Chemical class 0.000 description 2
- 239000013060 biological fluid Substances 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000003760 magnetic stirring Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- PSZYNBSKGUBXEH-UHFFFAOYSA-N naphthalene-1-sulfonic acid Chemical compound C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 238000003828 vacuum filtration Methods 0.000 description 2
- WLNBMPZUVDTASE-HXIISURNSA-N (2r,3r,4s,5r)-2-amino-3,4,5,6-tetrahydroxyhexanal;sulfuric acid Chemical compound [O-]S([O-])(=O)=O.O=C[C@H]([NH3+])[C@@H](O)[C@H](O)[C@H](O)CO.O=C[C@H]([NH3+])[C@@H](O)[C@H](O)[C@H](O)CO WLNBMPZUVDTASE-HXIISURNSA-N 0.000 description 1
- PLIKAWJENQZMHA-UHFFFAOYSA-N 4-aminophenol Chemical compound NC1=CC=C(O)C=C1 PLIKAWJENQZMHA-UHFFFAOYSA-N 0.000 description 1
- 235000011330 Armoracia rusticana Nutrition 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- IYXXQOGEFHAQGU-GPWRMYTLSA-N [(z)-(3-methyl-1,3-benzothiazol-2-ylidene)amino]azanium;chloride;hydrate Chemical compound O.Cl.C1=CC=C2S\C(=N/N)N(C)C2=C1 IYXXQOGEFHAQGU-GPWRMYTLSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003637 basic solution Substances 0.000 description 1
- ALIQZUMMPOYCIS-UHFFFAOYSA-N benzene-1,3-disulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC(S(Cl)(=O)=O)=C1 ALIQZUMMPOYCIS-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 239000007819 coupling partner Substances 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- GGCJLWBMJYGIRE-UHFFFAOYSA-N ethanol;formaldehyde Chemical compound O=C.CCO GGCJLWBMJYGIRE-UHFFFAOYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- UPBDXRPQPOWRKR-UHFFFAOYSA-N furan-2,5-dione;methoxyethene Chemical compound COC=C.O=C1OC(=O)C=C1 UPBDXRPQPOWRKR-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- JHGVLAHJJNKSAW-UHFFFAOYSA-N herniarin Natural products C1CC(=O)OC2=CC(OC)=CC=C21 JHGVLAHJJNKSAW-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- DKAGJZJALZXOOV-UHFFFAOYSA-N hydrate;hydrochloride Chemical compound O.Cl DKAGJZJALZXOOV-UHFFFAOYSA-N 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000010339 medical test Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 150000001451 organic peroxides Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- GNURASXBKKXAOM-JGWLITMVSA-N oxido-[(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexylidene]oxidanium Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=[O+][O-] GNURASXBKKXAOM-JGWLITMVSA-N 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920005597 polymer membrane Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000003839 salts Chemical group 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- DZLFLBLQUQXARW-UHFFFAOYSA-N tetrabutylammonium Chemical compound CCCC[N+](CCCC)(CCCC)CCCC DZLFLBLQUQXARW-UHFFFAOYSA-N 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Abstract
The present invention relates to a coupled dye compound for use in a test de that contains a reagent system for detecting the presence of an amount of an analyte in a sample. The reagent system comprises one or more enzymes which, in the presence of the analyte, produce an oxidizing agent in amounts indicative of the amount of analyte in the sample, the compound of choice being meta-methyl-2-benzothiazolinone-hydrozone] N-sulfonylbenzenesulfonate -monosod
Description
COLORONTE COPUlDOR Pft Q SPECTRROFOTOflETRICAL DETERMINATION PE ñNLITQS CflflPQ TÉCNICO
The present invention relates to a device and a test method for the color determination of chemical compounds and chemistries (analytes) in aqueous fluids, such as whole blood and, more particularly, to a pair of colorants for use on said device. and everything.
Lñ TECHNICAL PE BACKGROUND
The quantification of chemical and biochemical components in colored aqueous fluids, in particular colored biological fluids, such as whole blood and urine and in biological fluid derivatives, such as serum and plasma, are of increasing importance. There are important applications in medical diagnosis and treatment and in the quantification of exposure to therapeutic drugs, intoxicants, dangerous chemical substances and the like. In some cases, the quantities of ina + enals to be determined are + an lowercase (on a scale of 1 μg or less per deciliter) or so difficult to determine with precision that the apparatus used is complicated and only useful. for expert laboratory personnel. In that case, the results are usually not available for a few hours or days after the sample is taken. In other cases, there is often an emphasis on the ability of lay operators to routinely perform the test quickly and reproducibly outside a laboratory facility, with rapid and immediate display of information. A common medical test is the measurement of blood glucose levels by diabetics. Current teaching advises diabetic patients to measure their blood glucose level two to seven times a day, depending on the nature and severity of their individual cases. Based on the pattern observed in the measured glucose levels, the patient and the doctor together make adjustments in diet, exercise and ingestion of insulin for the best management of the disease. Clearly this information must be available immediately to the patient. Many blood glucose test methods and test items have been known in the art; They all suffer from a variety of limitations. A great improvement is described and claimed in U.S. Patent Nos. 4,935,345; 5,049,487; 5,059,394 and 5,179,005 of R. Phillips and co-inventors, and that the same successor as the present application was assigned. The method described and claimed in these patents involves reading a reflective reader from an inert porous matrix impregnated with a reagent that will interact with the analyte to produce a light absorbing reaction product, when the fluid being analyzed is applied to the analyte. another surface and rotate through the matrix through the surface that is being read. The reagent includes glucose oxidase, an enzyme that consumes glucose in the sample to produce hydrogen peroxide which, in the presence of another enzyme, horseradish peroxidase, oxidizes a dye pair comprising 3-rnet? L-2-benzot hydrochloride azolmone hydrazone (M1T?) and acid 3-d? met? larn? nobenzo? co (DMPIB) to produce a blue tint. The refle measurement is carried out at two separate wavelengths. The concentration of glucose in the blood is determined based on the intensity of the color of the dye, with the help of a LED spectrototrórnet ro. In the co-pending U.S. patent application, serial number 245,940, filed May 19, 1994 (LF 30), a dye pair comprising 3-met? 1-2-benzoth-azolene hydrazone in free form or in the form of acid (MBTH) and 1-naphthalenesulphonate 1-an? Lmo in the form of acid or in salt form (RN5) to be used in place of the coloring BTH-DMAB, such as described above. The MBTH-RNS dye pair is less soluble by oxidation and, therefore, provides a stable end point with minimal colorant dimming, in comparison with the oxidized MBTH-DriRB colorant. While these prior systems have actually been employed to produce test devices useful for determining the presence or amount of glucose, several drawbacks have been noted. Test devices in which several pairs are employed are designed for both domestic and institutional use and are thus sold by manufacturers and distributors in the hope that they remain in the user's inventory for a substantial period of time. time and, of course, must remain effective during that period of time. This need for a substantial shelf life has caused difficulties in formulating products that employ MBTH as one of the components of a dye pair. First, it has been found that MBTH stability decreases with increasing temperature and alkalinity. The free acid form of MBTH is very susceptible and tends to sublimate. In an attempt to account for this, a preterm form is ol acid hydrate of MBTH, for example, the hydrochloride of 3-rnet? ] -2-benzot? Azol? Nona hydrazone. Unfortunately this hydrate itself is unstable as the temperature increases and it dissociates easily to the free acid MBTH and HC1 when heated. In addition to having low stability at a high pH, the efficiency of MBTH to react oxidant with its counterpart of the pair, greatly decreases with increasing alkalinity, so that at a high pH there is essentially little or no color from the pair Colorant.
In view of these relationships, in practice, the MBTH should be used in large excesses and at a low pH to minimize the effects of instability and inadequacy. Ideally, a pH of less than 2.0 would be preferred from the point of view of the sublimation ba a and the high efficiency of the compound. Unfortunately, for the systems that are being considered in the present, said ideal low pH can not be employed. As described above, the reactive systems used depend on enzymes that act on the substrate analyte and generate oxidation agents in amounts indicative of the amounts of the analyte present in the sample being tested. The low pH, which would be ideal with respect to the MBTH reagent, is totally inadequate for such enzymes as, for example, glucose oxidase and horseradish peroxidase, said low pH, many of the commercially available enzymes have little or no activity. Consequently, the technique has been forced to consider and select a moderate pH, for example 4 and a large excess of reagents to guarantee the efficiency of its test devices, for the required storage life.
BRFVF DESCRIPTION OF THE INVENTION
In accordance with the teachings of this invention, a highly stable component of a color-ante pair is provided in a test device containing enzymes. The component, in contrast to those employed in the above test devices, is capable of oxidatively coupling efficiently with a wide variety of coupling counterparts at relatively high pH conditions compatible with the high efficiency of the enzymes. Specifically, the dye couple compound of this invention is to be used in a test device that contains a reactive system for detecting the presence or amount of an analyte in a sample, wherein the reactive system comprises one or more enzymes that, in the presence of the analyte, they produce an oxidizing agent in amounts indicative of the amount of the analyte present in the sample. In accordance with the teachings herein, the reactive system further comprises a dye pair capable of forming a chromium forum when oxidized by the oxidizing agent produced; and the dye pair comprises the compound:
wherein R is selected from the group consisting of alkyl, substituted alkyl, aryl, substituted aryl, heterocyclic, quaternary amine or organic acid portions; and Y is selected from the group consisting of NOs, S03-, H, halide, alkyl or 5? Za, wherein Z is alkyl or aryl. Preferably, Y is H. In a preferred embodiment, R is:
wherein any of R, Rs "and Ra is independently selected from the group consisting of H, alkyl, aplo, silyl, halide, hydroxide, ercaptide, alkoxide, thioalkoxide, amine, sulfonate or carboxylate; and X is selected from the group consisting of amine, sulfonate or carboxylate. In a specific embodiment, the test device is provided to determine the presence or amount of analytes such as glucose, cholesterol, alcohol, unco acid, formaldehyde or glycerol 3-phosphate, all blood analytes, commonly measured. In such cases, the enzyme system comprises enzymes selected from the group consisting of glucose oxidase, cholesterol oxidase, alcohol oxidase, upcase, aldehyde oxidase and glycerophosphate oxidase; together with peroxidase or an inorganic complex that has peroxidase-like activity, for example, atma, hernin and tetrakis-csulf- "ofeml3-orf? r? na-rnanganeso." A selection peroxidase is horseradish peroxidase.
BREVF DESCRIPTION OF THE DRAWINGS
Figure 1 is a perspective view of an embodiment of a test device containing a reaction pad to which the liquid sample being analyzed is applied; and Figure 2 is a perspective view of a second embodiment of the test device of Figure 1.
DISCUSSION PETRLLRPñ PE Lñ INVENCIÓN
As described above, the invention involves an improved dye compound for use in a test device for determining the presence or amount of an analyte in a liquid sample. With reference to Figure 1, in a preferred embodiment of this invention, the test device comprises a porous matrix 10 having a chemical reagent system incorporated therein and which is adhered to a support 12. It is provided with an opening 16 through the support, by which a liquid sample can be applied to a sample receiving surface 17 of the matrix 10. The chemical system is provided to react with any analyte present in the liquid sample and as a result of which a surface of test 19 of the matrix with a manifest luminous reflection, indicating the amount of analyte present in the liquid sample. The test surface can be read at a glance, but is preferably read by using a photometpco spectrum matrix device. The elements of said devices are shown schematically in FIG. 1 and comprise a light source 18, such as a light emitting diode for preferably directing a light of uniform wavelength on the test surface 19. The light detector 20 for detecting light reflected from surface 19 and producing a signal 22 indicating the amount of light detected, which signal can be processed, for example, by a microprocessor incorporated in the reading device? ar-to calculate the amount of analyte present in the sample. Systems such as that described above are known in the art and are well described in U.S. Patent Nos. 4,935,345; 5,049,487; 5,059,394 and 5,179,005. Said systems contemplate that these test devices will be inserted into the reader section and then a sample, for example blood, will be applied to the sample receiving surface 17. Figure 2 represents an alternative to this, where the blood is first applied to the sample receiving surface 7 and only then is the test surface 19 presented to the display for reading. In all other senses, the elements numbered in Figure 2 are identical to those in Figure 1. The reflective properties of the test surface vary with the amount of analyte present in the sample by the operation of a series of reactions. between the analyte present in the liquid sample and the chemical reagents present in the porous matrix. In particular, the matrix includes one or more enzymes which, together with the analyte substitute, result in the production of hydrogen peroxide or other strong oxidizing agents. A colorant is included in the matrix, ie, two compounds that are capable of being oxidized to form a chromophore that absorbs light at a specific wavelength, in proportion to the amount of chromophore present. The oxidizing agent formed by the enzyme-catalyzed reaction then reacts with the dye sample to produce the chromophore. The selection of the enzymes, the resulting oxidizing agent and the selection of the coloring pair vary widely in the art and, to a large extent, are a function of the analyte that is being determined. For example, in the case of the determination of cholesterol as in a blood sample, an enzyme oxidase, such as cholesterol oxidase can be employed. Similarly, alcohol oxidase can be used in the determination of methanol or ethanol; formaldehyde determinations may employ aldehyde-oxi dasa; or glycerol 3-phosphate determinations may employ glycerophosphate oxidase. The hydrogen peroxide product of these enzyme-catalyzed reactions can be further modified by a subsequent reaction catalyzed by an enzyme to produce a reactive oxidizing agent to react with the dye pair to form the chronophore. physiological, for example, the reaction of hydrogen peroxide to form an active oxidant reagent can be catalyzed by the horseradish peroxidase enzyme. Accordingly, while it will be understood that the teachings of this invention are broadly applicable, for the purpose of the discussion that follows, the analyte will be exemplified by glucose in a liquid sample of whole blood. The preferred chemical system will then be exemplified by the enzyme glucose oxidase which acts on the glucose substrate to form hydrogen peroxide. The hydrogen peroxide, in turn, is converted to the active oxidant reagent by reaction with another enzyme, horseradish peroxidase. Heretofore, the dye pair widely used in a glucose test of the type described above, was the combination of 3 ™ rnethyl-2-benzothiazolinone hydrazone hydrochloride hydrate (MBTH hydrochloride hydrate) (formula I), together with dirnetyl-n-benzene (formula II). These compounds undergo the following oxidation reaction to form a blue chromophore (formula III):
CO] = hydrogen peroxide / horseradish peroxidase As described above, this system suffers from several disadvantages. MBTH, even in the form of hydrochloride hydrate, is relatively unstable under the action of heat and alkalinity. Additionally, the above reaction is very inefficient under strongly acidic conditions, for example, pH 2 or less. Unfortunately, at those conditions the enzymes employed in the test devices, for example, glucose oxidase and horseradish peroxidase, have little or no activity. Accordingly, commercial practice has dictated that, in order to obtain a relatively stable system, an optimum pH be used, for example, about 4, and large amounts of enzymes and the coloring pair are used to constitute the decreased activity of the enzymes. and the reduced efficiency of the oxidation of the coupling reaction. In accordance with this invention, it has now been discovered that modified forms of MBTH can be provided that solve the stability problem hitherto encountered and are also efficiently reactive in an environment that further leads to the activity of the enzymes employed in the test employed here as, for example, at pH values ranging from 4 to 7, approximately. Some preferred derivatives, moreover, have been found to be highly reactive for the suitable coupling partners, the aromatic amines. The derivatives of the invention have the general structure indicated in formula IV that follows:
wherein R is selected from the group consisting of the alkyl, substituted alkyl, aplo, substituted aryl, heterocyclic, quaternary amine or organic acid moieties; and Y is selected from the group consisting of NOs ", S03-, H, halide, alkyl or S? Za, wherein Z is alkyl or ryl. Preferably Y is H. In a preferred embodiment R is:
wherein any of R, 2 and Ra is independently selected from the group consisting of H, alkyl, aryl, silyl, halide, hydroxide, cyclopentadide, alkoxide, thioalkoxide, amine, sulfonate or carboxylate; and X is selected from the group consisting of amine, sulfonate or carboxylate. The MBTH derivatives of this invention can be subjected to an oxidation reaction with a broad scale of dye pair partners, such as aromatic amines, phenols and substituted phenols. In addition, said reactions can proceed efficiently at room temperature, at pH values that can vary from 4 to 11. In the preferred form of the derivatives of this invention, the oxidation reaction is optimal at approximate pH values. from 4 to 7 and, therefore, is particularly useful in conjunction with the amine dye couple partners of interest in diagnostic chemistry, such as 3-d-r-ilanoinobenzoic acid and 1-naphthalensulphonates of 8-an ? l? no. In contrast to MBTH, either in the form of free acid or in the form of the acid hydrate, these derivatives are remarkably stable even when heated at 10 ° C for up to 1 (5 hours. oxidation, enzymes that catalyze peroxide, such as horseradish peroxide, are especially effective to carry out the coupling reaction by oxidation.
E3E11PLQ 1 SYNTHESIS BEL PERIVRPO PE? BTH
SYNTHESIS OF N-SULFONILBENCENSU FONRTO MONOSODIC C21 OF METAC3-METHYL-2-ENZOTITIZED INONfl HI RPZON 1
REACTION SCHEME
Material 3-Rhenethyl-2-benzothiazolinone hydrochloride (MBTH-HC1), Nal, hydroxide and tetrabutylammonium, methylene chloride and n-methyl-2-? -rolidolone were purchased from Rldrich Company of Milwau ee, Wisconsin, and are used without purification. Tpeti lamina is obtained from Baker Chemicals and distributed by Baxter-Company of Phillipsburg, New Jersey. Benzene 1,3-disulfonylchloride was purchased from Fluka Chemical, from Ronkonkona, New York or Lancaster Chemical from Umdharn, New Hanpshire.
Synthesis of (1) A sample of 4 g of MBTH-HC1 was loaded into an Erlen eyer 150-ml flask., equipped with magnetic stirring bar, and added 50 rnl of l-rnet? i ~? -p? rrol? dona and 5 ml of triethylanine. The flask was covered with a rubber septum and placed on a hot plate with magnetic stirring. The mixture was heated at 60-70 ° C while stirring vigorously for 0.5 hours, which produced a yellow suspension. The flask was placed in an ice bath to cool. A 5 g sample of 1,3-d-sulphonyl benzene fomlchloride was added to a 250 ml Erlenmeyer flask equipped with a magnetic stir bar. The flask was lowered onto an ice bath and 20 ml of n-met l-2-pyrrolidone was added. The mixture was stirred until all the solids had dissolved (approximately 15 minutes). The free base suspension of MBTH, which was previously obtained, was decanted over the solution. The resulting light yellow mixture was reacted at an ice bath temperature for 1.5 hours. After that time the reaction was quenched with 10 ml of 2 N HCl and stirred for another 30 minutes at room temperature. 50 ng of Nortí (activated carbon pellets) of 12 meshes were introduced into the solution, which produced a light yellow solution after 10 minutes of stirring. It was filtered through a fine grade fry with the help of a vacuum cleaner. A uniform yellow to light brown solution was obtained. 300 ml of 2 N HCl was added to the yellow solution which was stirred, resulting in the precipitation of a white matte powder. The solid was collected by vacuum filtration and the solid was washed three times with 25 ml of deionized water. Upon drying at 110 ° C under vacuum for 2 hours, 5.6 g of the white matte product was obtained. The product was analyzed with NMR with H and HPLC, yielding a purity of 97%. The compound (1) is not very soluble in most common organic solvents or in water. However, it is soluble in the basic solution and in polar solvents, such as DMSO, NMP and DMF.
Synthesis of (2) 2.0 g of crude oil sample (1) was suspended in 50 ml of methylene chloride. 4 ml of 1 M tetrabutyranonium hydroxide was slowly added over the course of 2 minutes to the suspension under stirring; which produced a light yellow solution. The solution was washed with 10 ml of deionized water and dried over anhydrous sodium sulfate. The sulfate was removed by gravity filtration and the resulting mixture was evaporated to dryness in a rotary evaporator. The thick yellow oil was collected. The oil was collected with 13
125 ml of acetone and 10 ml of 20% Nal in acetone was added over the course of 5 minutes. A white precipitate was evident. The mixture was allowed to react for another 20 minutes and the precipitate was collected by vacuum filtration with a fine grade fritter. The resulting white-matt solid was washed three times with 20 ml of acetone. On drying at 110 ° C for 45 minutes 1.3 g (65%) of the desired product was obtained. The compound (2) is very soluble in water and in a water-alcohol mixture. The solid is stable in air and light, but its solution slowly decomposes to a turbid, light yellow mixture when exposed to light for extended periods of time.
EXAMPLE 2 PREPRENCIATION PE A PISPQSITIVQ PE PROOF
A strip of polymer membrane (reaction matrix) is immersed in an aqueous immersion of table 1 until it becomes saturated. It is removed from the immersion and the excess reagent is squeezed with a glass rod. The strip is then hung inside a circulating air oven at 56 ° C for 5 to 10 minutes to dry, and after that time the strip is removed and immersed in the organic immersion described in table .1 until It is saturated. Again dry as in the previous step. The resulting strip is shaped as desired, to perform the test,
OUADRO i FORMULATION OF REAGENTS
Aqueous immersion Organic immersion (adjust pH to 4.25 with NaOH)
Rgua 20 mi Rgua 3 mi
Citric acid 420 my Ethyl diamine monoalonate alcohol 16.7 mg N-sulfonylbenzene 10-tetraacetic acid (EDTR) monosodium monohydrogen (2) meta-L "3-rnethyl-2-benzothiazolinone hydrazone] Gantrez S 5 90 rng flNS 10 - (obtainable from GRF, 100 mg New York, New York) Crotein SPA 250 ng (obtainable from Croda Co. New York, New York) Glucose-oxid sa 20,500 units Horseradish peroxidase 16,200 spicy units
EXAMPLE 3 ETERMINATION PE 6LUCQSR
A blood sample containing glucose is applied to the surface of the strip impregnated with the reagents.
The sample inside the matrix is immediately absorbed and a blue color is apparent. The intensity of color increases with time and is proportional to the concentration of the analyte. Based on the color intensity, the glucose concentration is determined by comparing with a standard calibration curve. Similarly, an aqueous solution of hydrogen peroxide (organic peroxides, ferric and quinone) also produces the desired blue color in the strip impregnated with reagent. The concentration of the analyte can be determined by the same means as above. The invention having been fully described, it will be evident to the person skilled in the art that any modification and change can be made therein without departing from the spirit and scope of the invention.
Claims (9)
1. - In a test device containing a reactive system for determining the presence or quantity of an analyte in a sample, wherein the reactive system comprises enzymes to produce an oxidizing agent in amounts that indicate the amounts of the analyte present in the sample; the improvement characterized in that: the r-active system comprises a dye pair that forms a chromophore when oxidized by said oxidizing agent; the dye pair comprising a compound having the formula: wherein R is selected from the group consisting of alkyl, substituted alkyl, aryl, substituted aryl, heterocyclic, quaternary amine or organic acid portions; and Y is selected from the group consisting of NOa, SOa-, H, halogenide, alkyl or S? Za, wherein Z is alkyl or an ilo.
2. The test device according to claim 1, further characterized in that R is: wherein any of R, R "and Ra are independently selected from the group consisting of H, alkyl, aryl, silyl, halide, hydroxide, mercaptide, alkoxide, thioalkoxide, amine, sulfonate or carboxylate; and X is selected from the group consisting of amine, sulfonate or carboxylate.
3. The test device according to claim 2, further characterized in that Y is H.
4. The test device according to claim 1, further characterized in that the enzymes are selected from the group consisting of glucose oxidase. , cholesterol oxidase, alcohol -oxidase, uricase, aldehyde oxidase and glycerophosphate -oxidase.
5. The test device according to claim 4, further characterized in that the enzymes additionally comprise peroxidase or an inorganic complex having properties similar to peroxidase.
6. The test device according to claim 4, further characterized in that the enzymes comprise gl? Seoxidase and horseradish peroxidase.
7. The test device according to claim 1, further characterized in that the dye pair further comprises 3-dirnethylaminobenzoic acid.
8. The test device according to claim 1, further characterized in that the dye pair additionally comprises 8-anilino l-naphthalene sulfonate.
9. The test device according to claim 1, further characterized in that the compound is monosodium N-sulfonylbenzenesulfonate of metaC3-methyl-2-benzothiazolinone hydrazone.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/302,575 US5563031A (en) | 1994-09-08 | 1994-09-08 | Highly stable oxidative coupling dye for spectrophotometric determination of analytes |
| US08302575 | 1994-09-08 | ||
| PCT/US1995/012091 WO1996007757A1 (en) | 1994-09-08 | 1995-09-07 | Dye couple for spectrophotometric determination of analytes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MXPA97001795A true MXPA97001795A (en) | 1997-06-01 |
| MX9701795A MX9701795A (en) | 1997-06-28 |
Family
ID=23168337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9701795A MX9701795A (en) | 1994-09-08 | 1995-09-07 | Highly stable oxidative coupling dye for spectrophotometric determination of analytes. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5563031A (en) |
| EP (2) | EP1167540B1 (en) |
| JP (1) | JP3755828B2 (en) |
| KR (1) | KR100402876B1 (en) |
| CN (1) | CN100357449C (en) |
| AT (2) | ATE365226T1 (en) |
| AU (1) | AU688138B2 (en) |
| CA (1) | CA2199490C (en) |
| DE (2) | DE69535522T2 (en) |
| DK (2) | DK0781350T3 (en) |
| ES (2) | ES2179885T3 (en) |
| MX (1) | MX9701795A (en) |
| NO (1) | NO318023B1 (en) |
| PT (2) | PT781350E (en) |
| WO (1) | WO1996007757A1 (en) |
Families Citing this family (122)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4935346A (en) | 1986-08-13 | 1990-06-19 | Lifescan, Inc. | Minimum procedure system for the determination of analytes |
| US5922530A (en) * | 1994-09-08 | 1999-07-13 | Lifescan, Inc. | Stable coupling dye for photometric determination of analytes |
| AU722471B2 (en) | 1995-10-17 | 2000-08-03 | Lifescan, Inc. | Blood glucose strip having reduced sensitivity to hematocrit |
| US5776719A (en) * | 1997-07-07 | 1998-07-07 | Mercury Diagnostics, Inc. | Diagnostic compositions and devices utilizing same |
| US5989845A (en) * | 1996-04-05 | 1999-11-23 | Mercury Diagnostics, Inc. | Diagnostic compositions and devices utilizing same |
| US6040151A (en) | 1998-03-10 | 2000-03-21 | Mercury Diagnostics, Inc. | Diagnostic compositions and devices utilizing same |
| US5962215A (en) | 1996-04-05 | 1999-10-05 | Mercury Diagnostics, Inc. | Methods for testing the concentration of an analyte in a body fluid |
| EP1579814A3 (en) | 1996-05-17 | 2006-06-14 | Roche Diagnostics Operations, Inc. | Methods and apparatus for sampling and analyzing body fluid |
| US20020010406A1 (en) | 1996-05-17 | 2002-01-24 | Douglas Joel S. | Methods and apparatus for expressing body fluid from an incision |
| US5846486A (en) * | 1996-08-09 | 1998-12-08 | Lifescan, Inc. | Hollow frustum reagent test device |
| US5753429A (en) * | 1996-08-09 | 1998-05-19 | Lifescan, Inc. | Analyte concentration measurement using a hollow frustum |
| US5736103A (en) | 1996-08-09 | 1998-04-07 | Lifescan, Inc. | Remote-dosing analyte concentration meter |
| US6099802A (en) * | 1996-08-09 | 2000-08-08 | Lifescan, Inc. | Hollow frustum reagent test device |
| GB2332943B (en) * | 1996-10-30 | 2000-01-19 | Mercury Diagnostics Inc | Detection device |
| US5948695A (en) * | 1997-06-17 | 1999-09-07 | Mercury Diagnostics, Inc. | Device for determination of an analyte in a body fluid |
| US6168957B1 (en) * | 1997-06-25 | 2001-01-02 | Lifescan, Inc. | Diagnostic test strip having on-strip calibration |
| US7390667B2 (en) | 1997-12-22 | 2008-06-24 | Roche Diagnostics Operations, Inc. | System and method for analyte measurement using AC phase angle measurements |
| US7407811B2 (en) | 1997-12-22 | 2008-08-05 | Roche Diagnostics Operations, Inc. | System and method for analyte measurement using AC excitation |
| US8071384B2 (en) | 1997-12-22 | 2011-12-06 | Roche Diagnostics Operations, Inc. | Control and calibration solutions and methods for their use |
| US7494816B2 (en) | 1997-12-22 | 2009-02-24 | Roche Diagnostic Operations, Inc. | System and method for determining a temperature during analyte measurement |
| US6391005B1 (en) | 1998-03-30 | 2002-05-21 | Agilent Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
| US6111639A (en) * | 1998-05-06 | 2000-08-29 | Reduto; Lawrence A. | Method and apparatus for countering adverse drug events |
| US6124242A (en) * | 1998-06-26 | 2000-09-26 | Basf Aktiengesellschaft | Herbicidal compositions and processes based on ferrodoxin:NADP reductase inhibitors |
| US6162397A (en) * | 1998-08-13 | 2000-12-19 | Lifescan, Inc. | Visual blood glucose test strip |
| WO2000012173A1 (en) | 1998-08-31 | 2000-03-09 | Johnson & Johnson Consumer Companies, Inc. | Electrotransport device comprising blades |
| US7700305B2 (en) | 1999-09-17 | 2010-04-20 | N2Itive1 Innovations | Analyte detection |
| US6656697B1 (en) * | 1998-09-28 | 2003-12-02 | Lifescan, Inc. | Diagnostics based on tetrazolium compounds |
| US8419650B2 (en) | 1999-04-16 | 2013-04-16 | Cariocom, LLC | Downloadable datasets for a patient monitoring system |
| US6678554B1 (en) | 1999-04-16 | 2004-01-13 | Johnson & Johnson Consumer Companies, Inc. | Electrotransport delivery system comprising internal sensors |
| US6290646B1 (en) | 1999-04-16 | 2001-09-18 | Cardiocom | Apparatus and method for monitoring and communicating wellness parameters of ambulatory patients |
| US6762158B2 (en) | 1999-07-01 | 2004-07-13 | Johnson & Johnson Consumer Companies, Inc. | Personal care compositions comprising liquid ester mixtures |
| US7074747B1 (en) | 1999-07-01 | 2006-07-11 | Johnson & Johnson Consumer Companies, Inc. | Cleansing compositions |
| AU5764800A (en) | 1999-07-01 | 2001-01-22 | Johnson & Johnson Consumer Companies, Inc. | Cleansing compositions |
| US20050009717A1 (en) * | 1999-07-01 | 2005-01-13 | Lukenbach Elvin R. | Foaming make-up removing cleansing compositions |
| US6218571B1 (en) * | 1999-10-27 | 2001-04-17 | Lifescan, Inc. | 8-(anilino)-1-naphthalenesulfonate analogs |
| US6458326B1 (en) | 1999-11-24 | 2002-10-01 | Home Diagnostics, Inc. | Protective test strip platform |
| US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
| US6635439B2 (en) | 2000-12-21 | 2003-10-21 | Ethicon, Inc. | Hydrogen peroxide indicator employing enzyme and dye |
| US6562625B2 (en) | 2001-02-28 | 2003-05-13 | Home Diagnostics, Inc. | Distinguishing test types through spectral analysis |
| US7041068B2 (en) | 2001-06-12 | 2006-05-09 | Pelikan Technologies, Inc. | Sampling module device and method |
| WO2002100251A2 (en) | 2001-06-12 | 2002-12-19 | Pelikan Technologies, Inc. | Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties |
| WO2002100460A2 (en) | 2001-06-12 | 2002-12-19 | Pelikan Technologies, Inc. | Electric lancet actuator |
| US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
| US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
| EP1404235A4 (en) | 2001-06-12 | 2008-08-20 | Pelikan Technologies Inc | METHOD AND APPARATUS FOR INTEGRATED LANCET LAUNCH DEVICE ON BLOOD SAMPLING CARTRIDGE |
| US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
| US8337419B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| US6844149B2 (en) | 2001-06-29 | 2005-01-18 | International Business Machines Corporation | Method, system, and apparatus for measurement and recording of blood chemistry and other physiological measurements |
| US6749887B1 (en) | 2001-11-28 | 2004-06-15 | Lifescan, Inc. | Solution drying system |
| US6872358B2 (en) | 2002-01-16 | 2005-03-29 | Lifescan, Inc. | Test strip dispenser |
| US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7547287B2 (en) | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
| US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
| US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
| US7491178B2 (en) | 2002-04-19 | 2009-02-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
| US7713214B2 (en) | 2002-04-19 | 2010-05-11 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with optical analyte sensing |
| US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
| US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
| US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
| US7297122B2 (en) | 2002-04-19 | 2007-11-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
| US8360992B2 (en) | 2002-04-19 | 2013-01-29 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
| US7229458B2 (en) | 2002-04-19 | 2007-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7175642B2 (en) | 2002-04-19 | 2007-02-13 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
| US8372016B2 (en) | 2002-04-19 | 2013-02-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling and analyte sensing |
| US7331931B2 (en) | 2002-04-19 | 2008-02-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US7232451B2 (en) | 2002-04-19 | 2007-06-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
| US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
| TW568772B (en) * | 2002-12-31 | 2004-01-01 | Veutron Corp | Apparatus with a combination of a point light source and a single lens |
| US6900058B2 (en) * | 2003-03-11 | 2005-05-31 | Bionostics, Inc. | Control solution for photometric analysis |
| DE602004028463D1 (en) | 2003-05-30 | 2010-09-16 | Pelikan Technologies Inc | METHOD AND DEVICE FOR INJECTING LIQUID |
| EP1633235B1 (en) | 2003-06-06 | 2014-05-21 | Sanofi-Aventis Deutschland GmbH | Apparatus for body fluid sampling and analyte sensing |
| WO2006001797A1 (en) | 2004-06-14 | 2006-01-05 | Pelikan Technologies, Inc. | Low pain penetrating |
| US8058077B2 (en) | 2003-06-20 | 2011-11-15 | Roche Diagnostics Operations, Inc. | Method for coding information on a biosensor test strip |
| US7597793B2 (en) | 2003-06-20 | 2009-10-06 | Roche Operations Ltd. | System and method for analyte measurement employing maximum dosing time delay |
| US7718439B2 (en) | 2003-06-20 | 2010-05-18 | Roche Diagnostics Operations, Inc. | System and method for coding information on a biosensor test strip |
| US7488601B2 (en) | 2003-06-20 | 2009-02-10 | Roche Diagnostic Operations, Inc. | System and method for determining an abused sensor during analyte measurement |
| US7645373B2 (en) | 2003-06-20 | 2010-01-12 | Roche Diagnostic Operations, Inc. | System and method for coding information on a biosensor test strip |
| US8206565B2 (en) | 2003-06-20 | 2012-06-26 | Roche Diagnostics Operation, Inc. | System and method for coding information on a biosensor test strip |
| US8148164B2 (en) | 2003-06-20 | 2012-04-03 | Roche Diagnostics Operations, Inc. | System and method for determining the concentration of an analyte in a sample fluid |
| US7604721B2 (en) | 2003-06-20 | 2009-10-20 | Roche Diagnostics Operations, Inc. | System and method for coding information on a biosensor test strip |
| US7645421B2 (en) | 2003-06-20 | 2010-01-12 | Roche Diagnostics Operations, Inc. | System and method for coding information on a biosensor test strip |
| US7452457B2 (en) | 2003-06-20 | 2008-11-18 | Roche Diagnostics Operations, Inc. | System and method for analyte measurement using dose sufficiency electrodes |
| US7220034B2 (en) * | 2003-07-11 | 2007-05-22 | Rudolph Technologies, Inc. | Fiber optic darkfield ring light |
| US8282576B2 (en) | 2003-09-29 | 2012-10-09 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for an improved sample capture device |
| US9351680B2 (en) | 2003-10-14 | 2016-05-31 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a variable user interface |
| US8450079B2 (en) | 2003-10-31 | 2013-05-28 | Immunetics, Inc. | Method for detecting bacteria |
| US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
| WO2005065414A2 (en) | 2003-12-31 | 2005-07-21 | Pelikan Technologies, Inc. | Method and apparatus for improving fluidic flow and sample capture |
| AU2005212396A1 (en) | 2004-02-06 | 2005-08-25 | Bayer Healthcare Llc | Oxidizable species as an internal reference for biosensors and method of use |
| EP1751546A2 (en) | 2004-05-20 | 2007-02-14 | Albatros Technologies GmbH & Co. KG | Printable hydrogel for biosensors |
| US9775553B2 (en) | 2004-06-03 | 2017-10-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
| EP1765194A4 (en) | 2004-06-03 | 2010-09-29 | Pelikan Technologies Inc | METHOD AND APPARATUS FOR MANUFACTURING A DEVICE FOR SAMPLING LIQUIDS |
| US7556723B2 (en) | 2004-06-18 | 2009-07-07 | Roche Diagnostics Operations, Inc. | Electrode design for biosensor |
| US7569126B2 (en) | 2004-06-18 | 2009-08-04 | Roche Diagnostics Operations, Inc. | System and method for quality assurance of a biosensor test strip |
| US20060002817A1 (en) * | 2004-06-30 | 2006-01-05 | Sebastian Bohm | Flow modulation devices |
| US8343074B2 (en) | 2004-06-30 | 2013-01-01 | Lifescan Scotland Limited | Fluid handling devices |
| US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
| CN103558284B (en) | 2005-07-20 | 2017-04-12 | 安晟信医疗科技控股公司 | Gated amperometry |
| EP3483598B1 (en) | 2005-09-30 | 2024-11-06 | Ascensia Diabetes Care Holdings AG | Gated voltammetry |
| US20070267513A1 (en) * | 2006-05-17 | 2007-11-22 | Taylor William A | Low profile fountain or water display |
| US10254229B2 (en) | 2007-04-18 | 2019-04-09 | Ondavia, Inc. | Portable water quality instrument |
| US20080294024A1 (en) * | 2007-05-24 | 2008-11-27 | Cosentino Daniel L | Glucose meter system and monitor |
| WO2009076302A1 (en) | 2007-12-10 | 2009-06-18 | Bayer Healthcare Llc | Control markers for auto-detection of control solution and methods of use |
| US9386944B2 (en) | 2008-04-11 | 2016-07-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte detecting device |
| US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
| US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| CN107024474B (en) | 2012-06-22 | 2020-11-06 | 霍夫曼-拉罗奇有限公司 | Methods and devices for detecting analytes in body fluids |
| US9395234B2 (en) | 2012-12-05 | 2016-07-19 | Cardiocom, Llc | Stabilizing base for scale |
| US11867631B2 (en) | 2014-03-05 | 2024-01-09 | Ondavia, Inc. | Portable water quality instrument |
| WO2016014162A1 (en) | 2014-07-25 | 2016-01-28 | Becton, Dickinson And Company | Analyte test strip assays, and test strips and kits for use in practicing the same |
| CN105572065B (en) * | 2016-01-29 | 2018-08-21 | 福建医科大学 | Glucose determination reagent box based on platinum bismuth nanometer Mimetic enzyme |
| CN106323959B (en) * | 2016-08-09 | 2019-01-18 | 滁州学院 | A kind of colorimetric sensor containing benzothiazole bases dyestuff, preparation method and its application in the detection |
| US11002682B2 (en) | 2018-03-12 | 2021-05-11 | Ondavia, Inc. | Aldehyde detection and analysis using surface-enhanced Raman spectroscopy |
| US11994455B2 (en) | 2021-04-01 | 2024-05-28 | Ondavia, Inc. | Analyte quantitation using Raman spectroscopy |
Family Cites Families (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL268685A (en) * | 1960-09-01 | |||
| ES310641A1 (en) * | 1964-03-20 | 1965-07-01 | Boehringer & Soehne Gmbh | PROCEDURE FOR OBTAINING A DIAGNOSTIC MEANS FOR THE RECOGNITION OF THE CONSTITUENTS OF PURE BLOOD |
| US3552928A (en) * | 1967-07-19 | 1971-01-05 | Miles Lab | Whole blood separation means and test system using same |
| US3992158A (en) * | 1973-08-16 | 1976-11-16 | Eastman Kodak Company | Integral analytical element |
| FR2295419A1 (en) * | 1974-12-21 | 1976-07-16 | Kyoto Daiichi Kagaku Kk | REFLECTANCE MEASURING DEVICE AND COMPOSITE TEST PAPER STRUCTURE SUBJECT TO SUCH MEASUREMENT |
| JPS51114985A (en) * | 1975-04-01 | 1976-10-09 | Kyoto Daiichi Kagaku:Kk | Mothod to analyse urine, etc. |
| US4042335A (en) * | 1975-07-23 | 1977-08-16 | Eastman Kodak Company | Integral element for analysis of liquids |
| CA1095819A (en) * | 1977-01-14 | 1981-02-17 | Eastman Kodak Company | Element for analysis of liquids |
| US4119405A (en) * | 1978-02-13 | 1978-10-10 | Miles Laboratories, Inc. | Test means and method for interference resistant determination of oxidizing substances |
| US4255384A (en) * | 1978-08-14 | 1981-03-10 | Fuji Photo Film Co., Ltd. | Multilayered integral element for the chemical analysis of the blood |
| US4258001A (en) * | 1978-12-27 | 1981-03-24 | Eastman Kodak Company | Element, structure and method for the analysis or transport of liquids |
| JPS55164356A (en) * | 1979-06-08 | 1980-12-22 | Fuji Photo Film Co Ltd | Multi-layer analysis sheet for liquid sample analysis |
| US4816224A (en) * | 1980-08-05 | 1989-03-28 | Boehringer Mannheim Gmbh | Device for separating plasma or serum from whole blood and analyzing the same |
| GB2090659A (en) * | 1981-01-02 | 1982-07-14 | Instrumentation Labor Inc | Analytical device |
| GB2096314A (en) * | 1981-03-26 | 1982-10-13 | Lre Relais & Elektronik Gmbh | Apparatus for optoelectric evaluation of test paper strips |
| JPS57208997A (en) * | 1981-06-17 | 1982-12-22 | Fuji Photo Film Co Ltd | Liquid analyzing material for oxidase enzyme reaction system |
| DE3133826A1 (en) * | 1981-08-27 | 1983-03-10 | Boehringer Mannheim Gmbh, 6800 Mannheim | ANALYSIS TEST STRIP AND METHOD FOR THE PRODUCTION THEREOF |
| US5095026A (en) * | 1983-02-04 | 1992-03-10 | University Of Iowa Research Foundation | Prodrugs of carbonic anhydrase inhibitors |
| EP0171148B1 (en) * | 1984-06-13 | 1991-04-17 | ARES-SERONO RESEARCH & DEVELOPMENT LIMITED PARTNERSHIP | Devices for use in chemical test procedures |
| GB8420053D0 (en) * | 1984-08-07 | 1984-09-12 | Secr Social Service Brit | Enhanced luminescent/luminometric assay |
| DE3433946A1 (en) * | 1984-09-15 | 1986-03-27 | Boehringer Mannheim Gmbh, 6800 Mannheim | AGENT AND METHOD FOR DETECTING HYDROGEN PEROXIDE |
| US4682895A (en) * | 1985-08-06 | 1987-07-28 | Texas A&M University | Fiber optic probe for quantification of colorimetric reactions |
| US4714874A (en) * | 1985-11-12 | 1987-12-22 | Miles Inc. | Test strip identification and instrument calibration |
| DE3781008T2 (en) * | 1986-04-19 | 1993-04-15 | Sanwa Kagaku Kenkyusho Co | METHOD FOR MEASURING HYDROGEN PEROXIDE OR MEASURING A PEROXID-RELEASING ENZYME OR BIOCHEMICAL SUBSTRATE. |
| DE3618752A1 (en) * | 1986-06-04 | 1987-12-10 | Bayer Ag | 4,6-DINITROBENZTHIAZOLONE HYDRAZONE (2) |
| EP0253371A1 (en) * | 1986-07-15 | 1988-01-20 | Omron Tateisi Electronics Co. | Chemical level measurement device with easy action cover and single control mode selection capability |
| US5029583A (en) * | 1986-07-22 | 1991-07-09 | Personal Diagnostics, Inc. | Optical analyzer |
| US4935346A (en) * | 1986-08-13 | 1990-06-19 | Lifescan, Inc. | Minimum procedure system for the determination of analytes |
| US5059394A (en) * | 1986-08-13 | 1991-10-22 | Lifescan, Inc. | Analytical device for the automated determination of analytes in fluids |
| US4790979A (en) * | 1986-08-29 | 1988-12-13 | Technimed Corporation | Test strip and fixture |
| JPH07117492B2 (en) * | 1987-01-13 | 1995-12-18 | 富士写真フイルム株式会社 | Method for manufacturing chemical analysis slide |
| US4774192A (en) * | 1987-01-28 | 1988-09-27 | Technimed Corporation | A dry reagent delivery system with membrane having porosity gradient |
| JPH079069Y2 (en) * | 1987-11-24 | 1995-03-06 | オムロン株式会社 | Reflector for blank value measurement of biochemical measuring instrument |
| US4994238A (en) * | 1988-06-09 | 1991-02-19 | Daffern George M | Constant volume chemical analysis test device |
| US5215890A (en) * | 1988-11-03 | 1993-06-01 | Spyros Theodoropulos | Chromogenic substrate to peroxidase enzymes |
| US5236940A (en) * | 1988-12-15 | 1993-08-17 | Rhone-Poulenc Sante | Pharmaceutical compositions, 2-benzothiazolamine derivatives, and their preparation |
| US5252293A (en) * | 1989-01-17 | 1993-10-12 | Vladimir Drbal | Analytical slide with porous filter membrane |
| JP2790299B2 (en) * | 1989-02-01 | 1998-08-27 | 保土谷化学工業株式会社 | Penzothiazole derivative |
| GB8911462D0 (en) * | 1989-05-18 | 1989-07-05 | Ares Serono Res & Dev Ltd | Devices for use in chemical test procedures |
| US5306623A (en) * | 1989-08-28 | 1994-04-26 | Lifescan, Inc. | Visual blood glucose concentration test strip |
| DE4035052C2 (en) * | 1989-11-29 | 1995-06-08 | Boehringer Mannheim Gmbh | Test vehicle analyzer |
| DE4015157A1 (en) * | 1990-05-11 | 1991-11-14 | Miles Inc | ASYMETRIC SANDWICH MEMBRANES FOR DIAGNOSTIC TEST STRIPS |
| DE4015590A1 (en) * | 1990-05-15 | 1991-11-21 | Boehringer Mannheim Gmbh | TEST CARRIER FOR THE DETERMINATION OF IONS |
| US5167145B1 (en) * | 1990-09-19 | 2000-05-23 | David M Butler | Measurement of blood coagulation time using infrared electromagnetic energy |
| US5174963A (en) * | 1991-01-07 | 1992-12-29 | United Medical Manufacturing Company | Blood glucose reflectance meter including a null prompting means and a device for providing a constant brightness light |
| US5232668A (en) * | 1991-02-27 | 1993-08-03 | Boehringer Mannheim Corporation | Test strip holding and reading mechanism for a meter |
| US5246858A (en) * | 1991-02-27 | 1993-09-21 | Boehringer Mannheim Corporation | Apparatus and method for analyzing a body fluid |
| CA2088652C (en) * | 1992-02-03 | 2008-07-29 | Yeung S. Yu | Improved oxidative coupling dye for spectrophotometric quantitative analysis of analytes |
| GR1002549B (en) * | 1992-05-12 | 1997-01-28 | Lifescan Inc. | Fluid conducting test strip with Transport Medium |
| WO1994018559A1 (en) * | 1993-02-11 | 1994-08-18 | Radiometer Medical A/S | Asymmetric membrane sensor |
-
1994
- 1994-09-08 US US08/302,575 patent/US5563031A/en not_active Expired - Lifetime
-
1995
- 1995-09-07 KR KR1019970701485A patent/KR100402876B1/en not_active Expired - Fee Related
- 1995-09-07 DE DE69535522T patent/DE69535522T2/en not_active Expired - Lifetime
- 1995-09-07 DK DK95933199T patent/DK0781350T3/en active
- 1995-09-07 EP EP01203297A patent/EP1167540B1/en not_active Expired - Lifetime
- 1995-09-07 PT PT95933199T patent/PT781350E/en unknown
- 1995-09-07 PT PT01203297T patent/PT1167540E/en unknown
- 1995-09-07 AT AT01203297T patent/ATE365226T1/en active
- 1995-09-07 MX MX9701795A patent/MX9701795A/en unknown
- 1995-09-07 EP EP95933199A patent/EP0781350B1/en not_active Expired - Lifetime
- 1995-09-07 DE DE69527361T patent/DE69527361T2/en not_active Expired - Lifetime
- 1995-09-07 ES ES95933199T patent/ES2179885T3/en not_active Expired - Lifetime
- 1995-09-07 ES ES01203297T patent/ES2288906T3/en not_active Expired - Lifetime
- 1995-09-07 AU AU35956/95A patent/AU688138B2/en not_active Expired
- 1995-09-07 DK DK01203297T patent/DK1167540T3/en active
- 1995-09-07 JP JP50973096A patent/JP3755828B2/en not_active Expired - Lifetime
- 1995-09-07 CA CA002199490A patent/CA2199490C/en not_active Expired - Lifetime
- 1995-09-07 CN CNB951961047A patent/CN100357449C/en not_active Expired - Lifetime
- 1995-09-07 AT AT95933199T patent/ATE220423T1/en active
- 1995-09-07 WO PCT/US1995/012091 patent/WO1996007757A1/en not_active Ceased
-
1997
- 1997-03-05 NO NO19971012A patent/NO318023B1/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA97001795A (en) | Coloring copuard for anali spectrophotometric determination | |
| EP1167540B1 (en) | Dye couple for spectrophotometric determination of analytes | |
| CA2192744C (en) | Stable coupling dye for photometric determination of analytes | |
| MXPA96006509A (en) | Stainless coloring colorant for anali photometric determination | |
| AU781213B2 (en) | 8-(anilino)-1-naphthalenesulfonate analogs and their use in analyte detection assays | |
| US5453360A (en) | Oxidative coupling dye for spectrophotometric quantitive analysis of analytes | |
| EP0058334B1 (en) | Improved system for the determination of glucose in fluids | |
| RU2050546C1 (en) | Method and composition for determining general glucose contents in the whole blood | |
| CA1217999A (en) | Ascorbate interference-resistant composition, device and method for the determination of peroxidatively active substances | |
| JPH04237500A (en) | Composition and method for assay of ketone body | |
| JPH0532040B2 (en) | ||
| JP2516381B2 (en) | Method for quantifying hydrogen peroxide and reagent for quantifying the same | |
| HK1043610B (en) | Dye couple for spectrophotometric determination of analytes | |
| EP0476455B1 (en) | Phenyl-substituted 2-thiazolyl tetrazolium salt indicators |